Related Experiment Video
Updated: Jul 18, 2026

Quantitation of Endothelial Cell Adhesiveness In Vitro
Published on: June 18, 2015
Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure
Wei-Hsian Yin1, Jaw-Wen Chen, Mason Shing Young
1Division of Cardiology, Department of Internal Medicine, Cheng-Hsin Rehabilitation Medical Center, Taipei-Veterans General Hospital, Taiwan.
Insights
Increased adhesion of peripheral blood mononuclear cells (PBMCs) to endothelial cells is linked to worse outcomes in chronic heart failure (CHF) patients, suggesting a role in disease progression.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathophysiology
Background:
- Chronic heart failure (CHF) is associated with vascular inflammation and endothelial dysfunction.
- Activated peripheral blood mononuclear cells (PBMCs) and their adhesion to endothelium may play a role in CHF pathophysiology.
- This study investigates the clinical significance of PBMC activity in CHF patients.
Purpose of the Study:
- To investigate the clinical significance of PBMC activity in CHF patients.
- To determine if PBMC adhesiveness to endothelial cells correlates with disease severity and clinical outcomes.
- To explore the pathophysiological relevance of PBMC-endothelial cell interactions in CHF progression.
Main Methods:
- PBMCs were isolated from 34 CHF patients, 10 healthy controls, and 17 disease controls.
- PBMC adhesiveness to human aortic endothelial cells (HAECs) was measured with and without TNF-alpha stimulation.
- Major adverse cardiac events were tracked over a median follow-up of 182 days.
Main Results:
- PBMCs from severe CHF patients showed significantly higher adhesion to HAECs compared to controls and mild CHF patients.
- Endothelial adhesiveness of PBMCs positively correlated with circulating cell adhesion molecules (CAMs).
- Higher PBMC-endothelial cell adhesion levels were associated with significantly worse event-free survival (log rank test, p=0.0139).
Conclusions:
- Increased endothelial adhesiveness of PBMCs is a feature of severe CHF.
- This increased adhesiveness correlates with clinical outcomes, suggesting prognostic value.
- PBMC-endothelial cell interactions are likely pathophysiologically relevant to CHF progression.
Background:
Vascular inflammation and endothelial dysfunction are evident in patients with chronic heart failure (CHF). We hypothesized that circulating peripheral blood mononuclear cells (PBMCs) may be activated and the resultant increased endothelial monocyte adhesion may be functionally and pathophysiologically relevant in CHF. In the present study, we investigated the clinical significance of the activity of PBMCs in patients with CHF.
Methods:
PBMCs were isolated from 34 CHF patients, from 10 healthy volunteers (normal control group) and from 17 patients admitted for investigation of suspected coronary artery disease (disease control group). In each patient, the adhesiveness of PBMCs to cultured human aortic endothelial cells (HAECs) with or without tumor necrosis factor-alpha (TNF-alpha) stimulation was determined. Major adverse cardiac events (death, heart transplantation or hospitalization with worsening heart failure) were determined in the 34 CHF patients during a median follow-up period of 182 days.
Results:
Compared with those from both control groups and from mild CHF patients, PBMCs isolated from severe CHF patients adhered more to the HAECs. The endothelial adhesiveness of PBMCs correlated positively with the circulating levels of CAMs and can supply prognostic information in CHF patients. The difference between event-free curves based on the median levels of endothelial-PBMC adhesion was significant (log rank test, p=0.0139).
Conclusions:
Endothelial adhesiveness of PBMCs is increased and correlated to clinical outcomes, and may be pathophysiologically relevant to the progression of CHF.
More Related Videos
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
09:57Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations